Novartis AG downgraded by Deutsche Bank
Stocks in this Quantisnow insightHealth Care
Historical context for NVS
Across the 9 sessions after earlier NVS headlines, the stock closed higher 5 times and lower 3 times, with a median move of 1.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | NVS | SPY |
|---|---|---|---|
| Sep 10, 2026 | Novartis AG upgraded by HSBC Securities | +0.0% | -0.6% |
| Sep 9, 2026 | RBC Capital Mkts initiated coverage on Novartis AGand 1 other headline that session | -0.2% | -0.5% |
| Mar 11, 2026 | Novartis AG upgraded by Argus with a new price target | -3.6% | -0.1% |
| Feb 27, 2026 | Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy | +1.9% | -0.5% |
| Jan 27, 2026 | Citigroup initiated coverage on Novartis AG | +2.1% | +0.4% |
| Jan 6, 2026 | Novartis AG upgraded by Barclays | +3.2% | +0.6% |
Keep researching NVS
- What is Analyst downgrade?A sell-side analyst's move to a less favorable rating on a stock, such as from Buy to Hold, usually published with a lower price target and rationale.
- Analyst upgrades and downgradesAn analyst upgrade or downgrade is a change in a sell-side analyst's stock rating. Learn what Buy, Hold and Sell mean, how price targets work and which changes matter.
- NVS financial statementsRevenue, profit, cash flow and balance sheet from Novartis AG's SEC filings.
Quantisnow market dataNYSE
NVS
Novartis AG
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for NVS
Full NVS profile on Quantisnow Follow NVS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time